英文摘要 |
Background and Objective: The National Cholesterol Education Program's Adult Treatment Panel Ⅲ Report (NCEP ATP-Ⅲ) showed clusters of modifiable cardiovascular disease (CVD) risk factors, yet total cholesterol LDL-C, and other important risk factors were not included. The American Diabetes Association criticized this by stating that there was no clear basis for including/excluding CVD risk factors. The aim of the present study was to explore this controversy using exploratory factor analysis. Methods: A total of 579 participants including 367 men and 212 women (mean age 47.9±11.8) who underwent health examinations in a regional hospital in Taichung Taiwan between May and December 2007 were included. Factor analysis (principal component analysis with variance maximization rotation and orthogonal rotation) was performed. The 16 measured modifiable cardiovascular risks included smoking, alcohol intake, exercise habit, body mass index (body height and weight), waist circumference, total cholesterol, triglycerides, high density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C), fasting glucose, uric acid, aspartate aminotransferase, alanine aminotransferase (ALT) and mean arterial pressure (MAP) instead of systolic, as well as diastolic blood pressure. Results:Nine-10 highly congruent variables were included in the analyses to manage the highly variable correlations among the 16 defined variables. The Kaiser-Meyer-Olkin Measure of Sampling Adequacy was 0.6-0.7 and Bartlett's tests of sphericity all reached statistical significance. Three to five factors were extracted and the variances were 52.0%-68.2%. We found some of the clustering phenomenon for metabolic syndrome criteria as noted by NCEPATP Ⅲ. Smoking and alcohol intake made up a unique factor we named the habit factor. Conclusions: This study supported the finding of 5 cluster factors for as reported by NCEP ATP-Ⅲ. Smoking, alcohol intake, exercise habits, BMI, uric acid, ALT, total cholesterol and LDL-C were not t diagnostic criteria for the NCEP ATP-Ⅲ metabolic syndrome. |